Business & Finance
Vascular Solutions reports net sales in Q4 2006 of $11.5 million, up 30% over year ago
Published in Medical Letter on the CDC and FDA, March 4th, 2007
The company reported a net income for the fourth quarter of $90,000 compared to a net loss of $407,000 fourth quarter of 2005.
Among highlights for the quarter was receiving approval from the United States Food and Drug Administration (FDA) for the "pocket protector" indication for the use of the D-Stat Flowable hemostat following pacemaker and ICD implants.
Vascular Solutions also received FDA clearances to launch the new 023 version of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Drug Discovery
New findings from Center for Drug Evaluation and Research in the area of drug discovery described - Pharmacology
Researchers from Center for Drug Evaluation and Research publish new studies and findings in the area of pharmacology - Allergy & Immunology
Allergy Therapeutics reports positive phase 2 U.S. FDA meeting on Pollinex Quattro Ragweed - Benign Prostate Hypertrophy
Spectrum initiates phase 2b trial for ozarelix in patients with benign prostate hypertrophy - Business Update
Aastrom receives orphan drug designation from U.S. FDA for dilated cardiomyopathy - Business Update
Cutera introduces novel laser wavelength for cosmetic dermatology - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
